Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population

Disease Markers

Volumn 25, Issue 1, 2008, Pages 67-74

  Jaeger, Janaína P ^a   Mattevi, Vanessa S ^b   Callegari Jacques, Sidia M ^a   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

BMI; CNR1; Obesity; Polymorphisms; WHR

Indexed keywords

CANNABINOID 1 RECEPTOR;

ADULT; ALLELE; ARTICLE; CNR1 GENE; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; WAIST HIP RATIO;

EID: 50249131267     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/841490     Document Type: Article

References (33)

1. J. Aberle, I. Fedderwitz, N. Klages, E. George and F.U. Beil, Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet, Hormone and metabolic research 39 (2007), 395-397.
2. K.G.M.M. Alberti and P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation, Diabetic medicine: a journal of the British Diabetic Association 15 (1998), 539-553.
3. M. Bensaid, M. Gary-Bobo, A. Esclangon, J.P. Maffrand, G. Le Fur, F. Oury-Donat and P. Soubrié, The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells, Molecular pharmacology 63 (2003), 908-914.
4. M. Blüher, S. Engeli, N. Kloting, J. Berndt, M. Fasshauer, S. Bátkai, P. Pacher, M.R. Schön, J. Jordan and M. Stumvoll, Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity, Diabetes 55 (2006), 3053-3060.
5. D.E. Comings, Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene, Alcohol 16 (1998), 61-70.
6. D. Cota, G. Marsicano, M. Tschöp, Y. Grübler, C. Flachskamm, M. Schubert, D. Auer, A. Yassouridis, C. Thöne-Reineke, S. Ortmann, F. Tomassoni, C. Cervino, E. Nisoli, A.C. Linthorst, R. Pasquali, B. Lutz, G.K. Stalla and U. Pagotto, The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis, The Journal of clinical investigation 112 (2003), 423-431.
7. V. Di Marzo, M. Bifulco and L. De Petrocellis, The endocannabinoid system and its therapeutic exploitation, Nature reviews. Drug discovery 3 (2004), 771-784.
8. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Bátkai, Z. Járai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura and G. Kunos, Leptin-regulated endocannabinoids are involved in maintaining food intake, Nature 410 (2001), 822-825.
9. E. Fride, Y. Ginzburg, A. Breuer, T. Bisognot, V. Di Marzo and R. Mechoulam, Critical role of the endogenous cannabinoid system in mouse pup suckling and growth, European journal of pharmacology 419 (2001), 207-214.
10. W.T. Friedewald, R.I. Levy and D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clinical chemistry 18 (1972), 499-502.
11. D. Gadzicki, K. Müller-Vahl and M. Stuhrmann, A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene, Molecular and cellular probes 13 (1999), 321-323.
12. P. Gazzerro, M.G. Caruso, M. Notarnicola, G. Misciagna, V. Guerra, C. Laezza and M. Bifulco, Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population, International journal of obesity (2005) 12 (2007), 908-912.
13. M.R. Hoehe, L. Caenazzo, M.M. Martinez, W.T. Hsieh, W.S. Modi, E.S. Gershon and T.I. Bonner, Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15, The New biologist 3 (1991), 880-885.
14. T.L Horvath, Endocannabinoids and the regulation of body fat: the smoking is clearing. The Journal of clinical investigation 112 (2003), 323-326.
15. A.C. Howlett, The cannabinoid receptors. Prostaglandins & other lipid mediator 68-69 (2002), 619-631.
16. A.C. Howlett, M. Glass, M. Dragunow and R.L. Faull, Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain, Neuroscience 77 (1997), 299-318.
17. N. Jamshidi and D.A. Taylor, Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats, British journal of pharmacology 134 (2001), 1151-1154.
18. L. de Koning, A.T. Merchant, J. Pogue and S.S. Anand, Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies, European heart journal 28 (2007), 850-851.
19. D.K. Lahiri and J.I. Nurnberger, Rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies, Nucleic acids research 19 (1991), 5444.
20. J.C. Long, R.C. Williams and M. Urbanek, An E-M algorithm and testing strategy for multiple-locus haplotypes, American journal of human genetics 56 (1995), 799-810.
21. P. Monteleone, I. Matias, V. Martiadis, L. De Petrocellis, M. Maj and V. Di Marzo, Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa, Neuropsychopharmacology 30 (2005), 1216-1221.
22. T.D. Müller, K. Reichwald, A.K. Wermter, G. Brönner, T.T. Nguyen, S. Friedel, K. Koberwitz, S. Engeli, P. Lichtner, T. Meitinger, H. Schäfer, J. Hebebrand and A. Hinney, No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents, Molecular genetics and metabolism 90 (2007), 429-434.
23. A. Peeters, S. Beckers, I. Mertens, W. Van Hul and L. Van Gaal, The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men, Endocrine 31 (2007), 138-141.
24. T.V. Perneger, What's wrong with Bonferroni adjustments, BMJ 316 (1998), 1236-1238.
25. R.G. Pertwee, Cannabinoids and the gastrointestinal tract. Gut 48 (2001), 859-867.
26. D. Piomelli, The molecular logic of endocannabinoid signaling, Nature reviews. Neuroscience 4 (2003), 873-884.
27. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.C. Brelière and G. Le Fur, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS letters 350 (1994), 240-244.
28. P. Russo, P. Strazzullo, F.P. Cappuccio, D.A. Tregouet, F. Lauria, M. Loguercio, G. Barba, M. Versiero and A. Siani, Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men, The Journal of clinical endocrinology and metabolism 92 (2007), 2382-2386.
29. F.M. Salzano and M.C. Bortolini, The evolution and genetics of Latin American populations, Cambridge University Press, Cambridge, 2002.
30. W.C. Willett, Anthropometric measures and body composition, Oxford University Press, New York, 1998.
31. World Health Organization, Physical status: the use and interpretation of anthropometry, World Health Organization, Geneva, 1995.
32. World Health Organization, Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June 1997, World Health Organization, Geneva, 1998.
33. P.W. Zhang, H. Ishiguro, T. Ohtsuki, J. Hess, F. Carillo, D. Walther, E.S. Onaivi, T. Arinami and G.R. Uhl, Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse, Molecular psychiatry 9 (2004), 916-931.